CRP and cancer: As such, various peculiar blends of immune and inflammatory markers have been searched for their prognostic efficiency in GBM patients, in like manner their counterparts presenting with extracranial cancers: Neutrophils, lymphocytes, platelets, monocytes, NLR, PLR, C-reactive protein, albumin, PNI, GPS, SII, and CRP/Alb with results demonstrating strong and independent prognostic values for each parameter, separately [7–16].